Terms: = Gastric cancer AND JAK3, L-JAK, 3718, ENSG00000105639, P52333, JAKL, JAK-3, LJAK, JAK3_HUMAN AND Treatment
3 results:
1. miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the jak3/STAT3 signalling pathway.
Zhou C; Chen L; Chen R; Xu F; Huang Z; Huang R; Wang W; Xu Q
J Chemother; 2022 Feb; 34(1):35-44. PubMed ID: 34167436
[TBL] [Abstract] [Full Text] [Related]
2. Chemo-resistant gastric cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
[TBL] [Abstract] [Full Text] [Related]
3. Functional interleukin-4 receptor and interleukin-2 receptor common gamma chain in human gastric carcinoma: a possible mechanism for cytokine-based therapy.
Essner R; Huynh Y; Nguyen T; Rose M; Kojima M; Hoon DS
J Gastrointest Surg; 2001; 5(1):81-90. PubMed ID: 11309652
[TBL] [Abstract] [Full Text] [Related]
